Discover trends, market shifts, and competitive outlooks for the anti-neoplastic agents industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research
What Is the Estimated Market Size of the Anti-Neoplastic Agents Market In 2029?
The market size for anti-neoplastic agents has seen significant growth in recent years. This market is projected to increase from a value of $130.01 billion in 2024 to reach $142.82 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 9.9%. Factors contributing to this upward trend during the historical period include a rise in cancer cases, an increased need for treatments, a growing preference for minimally invasive cancer treatments, as well as a demand for cost-effective anti-neoplastic treatments.
Expectations are high for significant growth in the anti-neoplastic agents market over the upcoming years. Forecasts suggest an increase to $202.12 billion by 2029, with an impressive compound annual growth rate (CAGR) of 9.1%. Such optimistic projections are due mainly to factors such as patient enlightenment and awareness, government-driven initiatives, an upsurge in demand for individualized cancer treatment, and an increased focus on quality of life during cancer treatment. Additionally, key trends predicted within this period involve progress in oncological research, the production of targeted therapies, biotechnological innovations, and advancements in diagnostic equipment.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12901&type=smp
Which Factors and External Forces Are Driving Demand in the Anti-Neoplastic Agents Market?
An upswing in cancer incidences is projected to bolster the antineoplastic agent market’s expansion. Cancer comprises a group of diseases that originate in almost any organ or tissue when rogue cells multiply unchecked, beyond their typical boundaries, and either spread to various parts or invade nearby areas of the body. Antineoplastic agents are crucial in treating cancer by curtailing cancer cell proliferation and division through several methods, like causing DNA (Deoxyribonucleic acid) harm, disrupting the cell cycle and meddling with critical cellular pathways. As per the February 2024 forecast by the France-based International Agency for Research on Cancer (IARC), promoting global cooperation in cancer research, the cancer burden may escalate to over 35 million by 2050, marking a 77% surge from the projected 20 million in 2022. Consequently, the rise in cancer instances is spurring the antineoplastic agent market’s growth.
Market Driver for Anti-Neoplastic Agents: Elevated Investment in Cancer Research Fuels Anti-Neoplastic Agent Market’s Growth
Which Segments in the Anti-Neoplastic Agents Offer the Most Growth?
The anti-neoplastic agents market covered in this report is segmented –
1) By Type: Alkylating Agents, Antimetabolites, Hormones And Antagonists, Miscellaneous
2) By Disease Type: Gastrointestinal Cancer, Prostate Cancer, Lung Cancer, Breast Cancer, Other Disease Types
3) By End User: Hospitals, Clinics, Cancer Rehabilitation Centers, Ambulatory Surgical Centers
Subsegments:
1) By Alkylating Agents: Nitrogen Mustards, Alkyl Sulfonates, Nitrosoureas, Triazines
2) By Antimetabolites: Purine Analogues, Pyrimidine Analogues, Folate Antagonists
3) By Hormones and Antagonists: Estrogens and Antiestrogens, Androgens and Antiandrogens, Glucocorticoids
4) By Miscellaneous: Vinca Alkaloids, Taxanes, Antibiotic Antineoplastics, Targeted Therapy Agents
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=12901&type=smp
What Are the Fastest-Growing Geographies in the Anti-Neoplastic Agents Market?
North America was the largest region in the anti-neoplastic agents market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in anti-neoplastic agents market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
Which Cutting-Edge Market Trends Are Expected to Drive the Anti-Neoplastic Agents Market’s Growth?
Top firms in the anti-neoplastic agent market are prioritizing the development of clinical practices to maintain their market standing. Take for example, Novartis AG, a pharmaceutical corporation based in Switzerland, who in March 2022, secured approval from the Food and Drug Administration (FDA) for Pluvicto, marking it as the first ever targeted radioligand therapy designed to treat progressive, PSMA (Prostate-specific membrane antigen) positive metastatic castration-resistant prostate cancer (mCRPC). The recommendation is for 7.4 GBq (200 mCi) of Pluvicto to be given intravenously in six-week intervals, for no more than six doses, or until the disease progresses or the toxicity becomes unbearable, whichever occurs first. Patients with mCRPC who have previously undergone treatment are selected for Pluvicto therapy, relying on the PSMA expression in tumors, by utilizing Locametz or another PSMA-11 imaging agent authorized for this purpose.
View the full report here:
https://www.thebusinessresearchcompany.com/report/anti-neoplastic-agents-global-market-report
What Are the Key Elements That Define the Anti-Neoplastic Agents Market?
Anti-neoplastic agents refer to drugs that inhibit or destroy abnormal tissue growth, specifically targeting and combating cancerous cells in the body. They have a vital role in cancer treatment by disrupting the processes involved in tumor development and progression.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12901
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
